GeoWealth Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-903
Closed -$10.5K 1202
2025
Q2
$10.5K Buy
903
+469
+108% +$4.28K ﹤0.01% 1114
2025
Q1
$3.79K Buy
+434
New +$5.47K ﹤0.01% 1020
2024
Q1
Sell
-3,628
Closed -$203K 907
2023
Q4
$203K Buy
+3,628
New +$158K 0.02% 503

Other funds holding TXG

GeoWealth Management's TXG Position: Q3 2025 in Review

GeoWealth Management sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 903 shares — an estimated $10.5K sold.

GeoWealth Management first reported a position in TXG in Q4 2023 and held it in 3 quarters. The position peaked at $203K in Q4 2023. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • GeoWealth Management reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • GeoWealth Management sold 903 10x Genomics shares in Q3 2025, an estimated $10.5K.
  • GeoWealth Management first reported a position in 10x Genomics in Q4 2023 and held it in 3 quarters.
  • GeoWealth Management's 10x Genomics position peaked at $203K in Q4 2023.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on GeoWealth Management's 13F filing for Q3 2025, filed 13 Nov 2025.